CSIMarket Company Name, Ticker, Industry, else..


Iradimed Corporation  (IRMD)
Other Ticker:  
 

Iradimed Corporation

IRMD's Fundamental analysis



Looking into Iradimed growth rates, revenue grew by 15.86 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 1023

Medical Equipment & Supplies industry recorded growth of revenues by 2.27 %

Iradimed's net income grew by 43.9 % in II. Quarter 2024 year on year, above company average,

• More on IRMD's Growth


Iradimed
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Iradimed PEG ratio is at 1.09 Company is currently trading with Price to Cash flow multiple of 226.36 in trailing twelve-month period.
Company
34.01
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.1.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.2.


• More on IRMD's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0.78 $
 Dividend Yield TTM (%) 3.43 %
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.58
 Tangible Book Value (Per Share $) 6.03

Iradimed
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Iradimed PEG ratio is at 1.09 Company is currently trading with Price to Cash flow multiple of 226.36 in trailing twelve-month period.
Company
34.01
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 9.1.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.2.

Iradimed Price to Book Ratio is at 7.79 higher than Industry Avg. of -182.28, and higher than S&P 500 Avg. of 0

• More on IRMD's Valuation

•  Market Capitalization (Millions $) 620
•  Shares Outstanding (Millions) 13
•  Employees -
•  Revenues (TTM) (Millions $) 68
•  Net Income (TTM) (Millions $) 18
•  Cash Flow (TTM) (Millions $) 3
•  Capital Exp. (TTM) (Millions $) -3
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0.78 $
•  Dividend Yield TTM (%) 3.43 %
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 5.58
•  Tangible Book Value (Per Share $) 6.03

•  Market Capitalization (Millions $) 620
•  Shares Outstanding (Millions) 13
•  Employees -
•  Revenues (TTM) (Millions $) 68
•  Net Income (TTM) (Millions $) 18
•  Cash Flow (TTM) (Millions $) 3
•  Capital Exp. (TTM) (Millions $) -3


    IRMD's Profitability Comparisons
Iradimed achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 31.39 % from 26.98 % in I. Quarter.

Iradimed net profit margin of 27.34 % is currently ranking no. 7 in Medical Equipment & Supplies industry, ranking no. 34 in Healthcare sector and number 363 in S&P 500.


Profitability by Segment
Total 27.34 %



  Ratio
•   Capital Ratio (MRQ) 9.87
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.13
•  Asset Turnover Ratio (TTM) 0.79
•  Inventory Turnover Ratio (TTM) 1.4



Iradimed achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2024 to 31.39 % from 26.98 % in I. Quarter.

Iradimed net profit margin of 27.34 % is currently ranking no. 7 in Medical Equipment & Supplies industry, ranking no. 34 in Healthcare sector and number 363 in S&P 500.

• More on IRMD's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com